CNS stock icon

Cohen & Steers
CNS

$87.42
0.58%

Market Cap: $4.42B

 

About: Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests mainly in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for close to two thirds of its $79.3 billion in managed assets at the end of January 2024. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 42% (27%) of its managed assets (base management fees) from institutional clients, 45% (52%) from open-end funds, and 13% (21%) from closed-end funds.

Employees: 405

0
Funds holding %
of 6,686 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

924% more call options, than puts

Call options by funds: $297K | Put options by funds: $29K

95% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 22

21% more repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 73

10% more funds holding

Funds holding: 209 [Q1] → 230 (+21) [Q2]

4.46% more ownership

Funds ownership: 56.1% [Q1] → 60.56% (+4.46%) [Q2]

4% more capital invested

Capital invested by funds: $2.13B [Q1] → $2.22B (+$85.4M) [Q2]

50% less funds holding in top 10

Funds holding in top 10: 2 [Q1] → 1 (-1) [Q2]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$63
28%
downside
Avg. target
$78
11%
downside
High target
$92
5%
upside

2 analyst ratings

positive
50%
neutral
0%
negative
50%
Evercore ISI Group
John Dunn
50% 1-year accuracy
4 / 8 met price target
5%upside
$92
Outperform
Maintained
5 Sept 2024
UBS
Adam Beatty
30% 1-year accuracy
3 / 10 met price target
28%downside
$63
Sell
Maintained
10 Jul 2024

Financial journalist opinion

Based on 8 articles about CNS published over the past 30 days